Emergent BioSolutions (EBS) Income Statement

Click line-items for a historical chart and %

Revenues:
Product sales	96.7M
Contracts and grants	31.5M
Total revenues	142.91M
Operating expenses:
Cost of product sales	39.56M
Research and development	27.19M
Selling, general and administrative	40.69M
Income (loss) from operations	35.48M
Other income (expense):
Interest income	358K
Interest expense	-2.05M
Other income (expense), net	-234K
Total other income (expense)	-1.93M
Income (loss) before provision for (benefit from) income taxes	33.55M
Provision for (benefit from) income taxes	13.17M
Net income (loss)
Net loss attributable to noncontrolling interests
Net income (loss) attributable to Emergent BioSolutions Inc.	21.34M
Earnings per share - basic	0.52
Earnings per share - diluted	0.45
Weighted-average number of shares - basic	40.47M
Weighted-average number of shares - diluted	49.44M

Entities mentioned with EBS